An enhancer haplotype may influence BCL11A expression levels and the response to hydroxyurea in β-thalassemia patients

Precise gene deletion and replacement using the CRISPR/Cas9 system in human cells

(2016) Qiupeng Zheng et al.   BIOTECHNIQUES

Development and characterization of K562 cell clones expressing BCL11A-XL: Decreased hemoglobin production with fetal hemoglobin inducers and its rescue with mithramycin

(2015) Alessia Finotti et al.   EXPERIMENTAL HEMATOLOGY

Pharmacological Induction of Human Fetal Globin Gene in Hydroxyurea-Resistant Primary Adult Erythroid Cells

(2015) Yu-Chi Chou et al.   MOLECULAR AND CELLULAR BIOLOGY

BCL11A enhancer dissection by Cas9-mediated in situ saturating mutagenesis

(2015) Matthew C. Canver et al.   NATURE

Making sense of GWAS: using epigenomics and genome engineering to understand the functional relevance of SNPs in non-coding regions of the human genome

(2015) Yu Gyoung Tak et al.   Epigenetics & Chromatin

Red cells in post-genomic era: impact of personalized medicine in the treatment of anemias

(2015) A. Iolascon et al.   HAEMATOLOGICA

Variation in Gamma-Globin Expression before and after Induction with Hydroxyurea Associated with BCL11A, KLF1 and TAL1

(2015) Amanda J. Grieco et al.   PLoS One

Induction of adult levels of  -globin in human erythroid cells that intrinsically express embryonic or fetal globin by transduction with KLF1 and BCL11A-XL

(2014) K. Trakarnsanga et al.   HAEMATOLOGICA

Characterization of Genomic Deletion Efficiency Mediated by Clustered Regularly Interspaced Palindromic Repeats (CRISPR)/Cas9 Nuclease System in Mammalian Cells

(2014) Matthew C. Canver et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

High-efficiency genome editing via 2A-coupled co-expression of fluorescent proteins and zinc finger nucleases or CRISPR/Cas9 nickase pairs

(2014) Katarzyna Duda et al.   NUCLEIC ACIDS RESEARCH

An Efficient Genotyping Method for Genome-modified Animals and Human Cells Generated with CRISPR/Cas9 System

(2014) Xiaoxiao Zhu et al.   Scientific Reports

Enhancer variants: evaluating functions in common disease

(2014) Olivia Corradin et al.   Genome Medicine

Hydroxyurea treatment in β-thalassemia patients: to respond or not to respond?

(2013) Mehdi Banan   ANNALS OF HEMATOLOGY

Clinical experience with fetal hemoglobin induction therapy in patients with  -thalassemia

(2013) K. M. Musallam et al.   BLOOD

Analysis of off-target effects of CRISPR/Cas-derived RNA-guided endonucleases and nickases

(2013) S. W. Cho et al.   GENOME RESEARCH

To respond or not to respond to hydroxyurea in thalassemia: a matter of stress adaptation?

(2013) A. Ronchi et al.   HAEMATOLOGICA

Utility Of The Multivariate Approach In Predicting β-Thalassemia Intermedia Or β-Thalassemia Major Types In Iranian Patients

(2013) Mehdi Banan et al.   HEMOGLOBIN

Rewriting a genome

(2013) Emmanuelle Charpentier et al.   NATURE

Targeted genome engineering in human cells with the Cas9 RNA-guided endonuclease

(2013) Seung Woo Cho et al.   NATURE BIOTECHNOLOGY

Cas9 as a versatile tool for engineering biology

(2013) Prashant Mali et al.   NATURE METHODS

Genome engineering using the CRISPR-Cas9 system

(2013) F Ann Ran et al.   Nature Protocols

An Erythroid Enhancer of BCL11A Subject to Genetic Variation Determines Fetal Hemoglobin Level

(2013) D. E. Bauer et al.   SCIENCE

Pathophysiology and Clinical Manifestations of the  -Thalassemias

(2013) A. W. Nienhuis et al.   Cold Spring Harbor Perspectives in Medicine

Reawakening fetal hemoglobin: prospects for new therapies for the  -globin disorders

(2012) D. E. Bauer et al.   BLOOD

cAMP response element-binding protein 1 is required for hydroxyurea-mediated induction of γ-globin expression in K562 cells

(2012) Mehdi Banan et al.   CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY

Hydroxyurea responsiveness in  -thalassemic patients is determined by the stress response adaptation of erythroid progenitors and their differentiation propensity

(2012) F. Pourfarzad et al.   HAEMATOLOGICA

The XmnI andBCL11ASingle Nucleotide Polymorphisms May Help Predict Hydroxyurea Response in Iranian β-Thalassemia Patients

(2012) Mehdi Banan et al.   HEMOGLOBIN

Gene expression analysis of human red blood cells

(2012) Sveta Kabanova et al.   International Journal of Medical Sciences

Enhancers and silencers: an integrated and simple model for their function

(2012) Petros Kolovos et al.   Epigenetics & Chromatin

MBD2 contributes to developmental silencing of the human ε-globin gene

(2011) Jeremy W. Rupon et al.   BLOOD CELLS MOLECULES AND DISEASES

Thalassaemia

(2011) Douglas R Higgs et al.   LANCET

Binding patterns of BCL11A in the globin and GATA1 loci and characterization of the BCL11A fetal hemoglobin locus

(2010) Kiran Jawaid et al.   BLOOD CELLS MOLECULES AND DISEASES

Transcriptional silencing of  -globin by BCL11A involves long-range interactions and cooperation with SOX6

(2010) J. Xu et al.   GENES & DEVELOPMENT

BCL11A represses HBG transcription in K562 cells

(2009) Zhiyi Chen et al.   BLOOD CELLS MOLECULES AND DISEASES

Control of fetal hemoglobin: new insights emerging from genomics and clinical implications

(2009) S. L. Thein et al.   HUMAN MOLECULAR GENETICS

Copy number variants, diseases and gene expression

(2009) C. N. Henrichsen et al.   HUMAN MOLECULAR GENETICS

A cell stress signaling model of fetal hemoglobin induction: what doesn't kill red blood cells may make them stronger

(2008) Rodwell Mabaera et al.   EXPERIMENTAL HEMATOLOGY

Genetic complexity in sickle cell disease

(2008) D. R. Higgs et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Human Fetal Hemoglobin Expression Is Regulated by the Developmental Stage-Specific RepressorBCL11A

(2008) Vijay G. Sankaran et al.   SCIENCE